title: Tenofovir as a first line option for prophylaxis in a patient with hepatitis B virus associated nephrotic syndrome.
authors.forename: Selman
authors.initials: S
authors.lastname: Unverdi
authors.forename: Mevlut
authors.initials: M
authors.lastname: Ceri
authors.forename: Seyfettin
authors.initials: S
authors.lastname: Köklü
authors.forename: Hatice
authors.initials: H
authors.lastname: Unverdi
authors.forename: Erdem
authors.initials: E
authors.lastname: Koçak
authors.forename: Murat
authors.initials: M
authors.lastname: Duranay
mesh_terms: D000225:Adenine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000328:Adult; D001706:Biopsy; D006509:Hepatitis B / Q000150:complications*; D006515:Hepatitis B virus; D006801:Humans; D007668:Kidney / Q000473:pathology; D008297:Male; D009404:Nephrotic Syndrome / Q000517:prevention & control* / Q000821:virology; D063065:Organophosphonates / Q000627:therapeutic use*; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use*; D000068698:Tenofovir; D016896:Treatment Outcome
chemical_list: D063065:Organophosphonates; D018894:Reverse Transcriptase Inhibitors; D000068698:Tenofovir; D000225:Adenine